
FDA Clears First Blood Test For Alzheimer’s Diagnosis
Topline The first blood test used to diagnose Alzheimer’s disease was cleared by the Food and Drug Administration for marketing Friday, meaning the laboratory test can be marketed and sold in the U.S., a significant benchmark for detection of the brain disorder that affects 10% of people aged 65 and older. The clearance was announced…